Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-060128
Filing Date
2018-10-02
Accepted
2018-10-02 19:58:24
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4073
  Complete submission text file 0001104659-18-060128.txt   5575
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1903 CARPENTER STREET PHILADELPHIA PA 19146
Business Address
Binder-Scholl Gwendolyn Knowlton (Reporting) CIK: 0001662116 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 181103310